ANI Pharmaceuticals, Inc. (BST:BSFA)
Germany flag Germany · Delayed Price · Currency is EUR
54.50
+1.50 (2.83%)
At close: Jul 3, 2025

ANI Pharmaceuticals Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
1,1111,043952614678285
Upgrade
Market Cap Growth
-0.44%9.52%55.11%-9.53%138.20%-56.40%
Upgrade
Enterprise Value
1,5361,5291,063855850437
Upgrade
Last Close Price
54.0051.0048.6037.6040.8022.40
Upgrade
PE Ratio
--68.00---
Upgrade
PS Ratio
1.781.762.162.073.571.67
Upgrade
PB Ratio
2.712.522.301.942.151.78
Upgrade
P/TBV Ratio
--5.3819.3964.9496.52
Upgrade
P/FCF Ratio
18.0322.599.56-1008.4338.15
Upgrade
P/OCF Ratio
14.8716.868.85-232.2322.82
Upgrade
EV/Sales Ratio
2.682.582.412.894.472.57
Upgrade
EV/EBITDA Ratio
19.4319.2310.7526.9350.6418.40
Upgrade
EV/EBIT Ratio
124.01108.3123.73---
Upgrade
EV/FCF Ratio
24.9233.1410.67-1263.3158.56
Upgrade
Debt / Equity Ratio
1.421.470.620.850.801.02
Upgrade
Debt / EBITDA Ratio
6.777.442.618.2615.066.87
Upgrade
Debt / FCF Ratio
9.4613.202.60-375.6521.88
Upgrade
Asset Turnover
0.610.560.590.410.350.45
Upgrade
Inventory Turnover
2.182.021.681.481.411.60
Upgrade
Quick Ratio
1.861.932.632.152.611.32
Upgrade
Current Ratio
2.662.733.573.463.682.17
Upgrade
Return on Equity (ROE)
-4.57%-4.18%4.72%-13.74%-15.37%-11.04%
Upgrade
Return on Assets (ROA)
0.83%0.83%3.72%-2.10%-2.86%-2.12%
Upgrade
Return on Capital (ROIC)
0.99%1.01%4.52%-2.53%-3.38%-2.43%
Upgrade
Return on Capital Employed (ROCE)
1.30%1.30%6.50%---
Upgrade
Earnings Yield
-1.87%-1.72%1.79%-7.30%-5.52%-6.47%
Upgrade
FCF Yield
5.55%4.43%10.46%-6.11%0.10%2.62%
Upgrade
Payout Ratio
--8.65%---
Upgrade
Buyback Yield / Dilution
-2.79%-6.18%-11.89%-29.09%-5.28%0.63%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.